Credit Suisse’s Thermo Fisher Scientific TMO Stock Holding History

Credit Suisse’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-119,300	Closed	-$79.6M	–	4301
2021 Q4	$79.6M	Sell	119,300 -66,200	-36%	-$41.3M	0.04%	455
2021 Q3	$106M	Buy	185,500 +55,500	+43%	+$30.5M	0.06%	350
2021 Q2	$66.1M	Sell	130,000 -64,600	-33%	-$30.5M	0.04%	548
2021 Q1	$88.8M	Sell	194,600 -24,900	-11%	-$11.9M	0.05%	452
2020 Q4	$102M	Buy	219,500 +62,300	+40%	+$29.2M	0.05%	414
2020 Q3	$69.4M	Buy	157,200 +92,300	+142%	+$38.1M	0.04%	476
2020 Q2	$23.5M	Buy	64,900 +28,200	+77%	+$9.45M	0.02%	867
2020 Q1	$10.4M	Sell	36,700 -20,100	-35%	-$6.34M	0.01%	1167
2019 Q4	$18.5M	Buy	56,800 +23,700	+72%	+$7.19M	0.01%	1071
2019 Q3	$9.64M	Buy	33,100 +23,000	+228%	+$6.59M	0.01%	1330
2019 Q2	$2.97M	Buy	10,100 +4,700	+87%	+$1.29M	﹤0.01%	2160
2019 Q1	$1.48M	Buy	+5,400	New	+$1.34M	﹤0.01%	2593
2017 Q3	–	Sell	-46,200	Closed	-$8.06M	–	4260
2017 Q2	$8.06M	Buy	+46,200	New	+$7.76M	0.01%	1325

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Credit Suisse's TMO Position: Q1 2024 in Review

Credit Suisse increased its Thermo Fisher Scientific (TMO) stake by 5.5% in Q1 2024, buying an estimated $25.3M and bringing the position to 859,879 shares worth $500M. The position accounts for 0.48% of the portfolio, ranked #27.

Credit Suisse first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $777M in Q1 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

Credit Suisse held 859,879 shares of Thermo Fisher Scientific worth $500M as of Q1 2024.
Credit Suisse bought 45,128 Thermo Fisher Scientific shares in Q1 2024, an estimated $25.3M.
Thermo Fisher Scientific made up 0.48% of Credit Suisse's portfolio in Q1 2024, its #27 holding.
Credit Suisse first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
Credit Suisse's Thermo Fisher Scientific position peaked at $777M in Q1 2021.
2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.